February 1, 2024 · Form 4 insider transaction
Kemps-Polanco Reshema bought 399 shares of Charles River Laboratories International, Inc. at $219.54 per share, a transaction worth $87.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The stock options become exercisable 5/7/2024.